← Back to Clinical Trials
Recruiting NCT07148466

NCT07148466 Scapular and Upper Limb Proprioceptive Neuromuscular Facilitation Techniques in Stroke With Scapular Dyskinesia.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07148466
Status Recruiting
Phase
Sponsor Riphah International University
Condition Scapular Dyskinesis
Study Type INTERVENTIONAL
Enrollment 44 participants
Start Date 2025-08-19
Primary Completion 2026-01-20

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Scapular PNFConventional treatment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 44 participants in total. It began in 2025-08-19 with a primary completion date of 2026-01-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to fill this gap by investigating the effects of scapular and upper limb proprioceptive neuromuscular facilitation techniques on shoulder pain, upper limb function \& gait in stroke with scapular dyskinesia. This study is a randomized control trial that includes 44 patients which were randomly divided into two groups each containing 22 participants. Experimental group will receive scapular PNF coupled with upper limb PNF and conventional physiotherapy treatment and Control group will receive only Conventional treatment.

Eligibility Criteria

Inclusion Criteria: * • Sub-acute * MCA * Age bracket 40-65 years. * Gender Male or Female. * Gait baseline score (DGI less than 19) * Patients with spasticity between grades (+1 and 1) on the Modified Ashworth Scale (MAS). Exclusion Criteria: * • Inability to communicate/understand instructions. * Stroke with other neurological conditions. * Patient with any other psychological and medical condition.

Contact & Investigator

Central Contact

Mahat zafar, MSNMPT

✉ mahat.zafar@riphah.edu.pk

📞 03326624087

Principal Investigator

Mahat zafar, MSNMPT

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT07148466 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, up to 65 Years, studying Scapular Dyskinesis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07148466 currently recruiting?

Yes, NCT07148466 is actively recruiting participants. Contact the research team at mahat.zafar@riphah.edu.pk for enrollment information.

Where is the NCT07148466 trial being conducted?

This trial is being conducted at Islamabad, Pakistan, Islamabad, Pakistan.

Who is sponsoring the NCT07148466 clinical trial?

NCT07148466 is sponsored by Riphah International University. The principal investigator is Mahat zafar, MSNMPT at Riphah International University. The trial plans to enroll 44 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology